What is the future outlook of the COVID-19 pandemic? Experts discussed where we are and the path forward on February 17, 2022 in a Fearless Science Speaker Series webinar.
After years of sharpening her knowledge of mass spectrometry in the Josh Coon Lab, chemistry PhD alumna Anji Trujillo landed her dream job of working on the front lines of drug development at Pfizer in St. Louis.
A new digital learning resource developed by PBS Wisconsin called “Meet the Lab,” which gives middle school-aged students a glimpse into high-powered research labs and the scientists who run them, highlights the Morgridge Institute virology research team.
Over 18 months into the COVID-19 pandemic, and vaccines are now available for children 5-11. Experts on the front lines of pediatric vaccine development and public health addressed questions during a Fearless Science Speaker Series webinar on November 9, 2021.
When dangerous COVID viral variants were sweeping the globe, David O’Connor was busy tracking their spread in Wisconsin. His secret weapon? High-throughput computing.
The impacts of COVID-19 are improving worldwide. But virology experts argue we must stay vigilant to protect public health for a safer, more productive future.
The COVID-19 pandemic is not an isolated event, but one step in an accelerating progression of viral threats. Preventing the next pandemic will take a massive scientific commitment.
Multiple COVID-19 vaccines are available, but some people are on the fence about getting their shot. Approaching a conversation with vaccine-hesitant friends and family may be challenging. Three scientists and public health experts spoke to more than 250 members during a Fearless Science Seminar Series.
Johan den Boon, anesthesiologist Dr. Bill Hartman, and pediatric infectious disease specialist Dr. James Conway presented for a webinar about the science of vaccines.
Engineers are well-equipped to address the world’s development challenges, but good engineering alone is not enough. We need the emerging field of ‘global engineering,’ argues Kevin Eliceiri, a Morgridge medical engineering investigator, and Rebecca Alcock, a recent alumna of the UW-Madison graduate program in biomedical engineering.
Morgridge bioethicist in residence Pilar Ossorio, Jonathan Kimmelman, and Seema Shah joined Gabriella Gerhardt on October 27 to discuss the complex ethical questions surrounding a coronavirus vaccine.
Researchers have identified more than 200 molecular features that strongly correlate with COVID-19 severity.
As health officials move closer to developing safe vaccines against COVID-19, Morgridge virology expert Paul Ahlquist argues for the need for patience and trust during what will be the largest vaccination effort in more than 70 years.
The workshop series, which wrapped up in late July, brought more than 100 students and 15 teachers “face-to-face” to learn online from scientists at the Morgridge Institute for Research.
Why is it that some COVID-19 patients become extremely ill and die, while others experience only mild symptoms? A new study uses mass spectrometry, RNA sequencing, and machine learning to explore the molecular traits that might influence the severity of the disease.
Morgridge scientists John Brubacher, Anthony Gitter, Brian Bockelman, Ben Cox and Katie Overmyer, joined Gabriella Gerhardt on July 22 for a Fearless Science webinar about rapidly applying technology and methods to answer COVID-19 questions.
The scientific community’s shift on wearing masks to fight the pandemic tells us something important about the scientific process. Science can get things wrong, but the constant push for new knowledge — combined with an ability to admit and correct mistakes — should always prevail.
The deadliest cases of COVID-19 often arise in patients with a variety of pre-existing conditions, known to medicine as “comorbidity.” A Morgridge Institute for Research project will investigate those disease relationships in the search for new drug treatments.
In light of the COVID-19 pandemic, Paul Ahlquist and Tony Gitter joined CEO Brad Schwartz in a webinar where they discussed COVID-19 and the broader context of viral pandemics and how we respond to them.
A Morgridge Institute for Research project intended to shed light on planarians — remarkable flatworms capable of almost limitless regeneration — is being repurposed to focus on the novel coronavirus causing COVID-19.
Morgridge virology investigator Anthony Gitter, an assistant professor of biostatistics and medical informatics at UW-Madison, has co-developed a software tool called Manubot to help orchestrate a rapid expert assessment of COVID-19 diagnostics and therapeutics.
In the center of the COVID-19 pandemic, many hospitals are racing to maintain quality care for patients with severe disease while facing a shortage of resources and limited understanding of the novel coronavirus.
Given the death toll and multi-trillion dollar costs of COVID-19, it’s not hyperbole to suggest that an effort on the scale of the Space Race is needed to break the cycle of viral pandemics.
Bioethicist Pilar Ossorio says the world could be at risk of sacrificing essential knowledge for fighting COVID-19 and future deadly viruses if the COVID-19 response is not accompanied by sound research.
Morgridge CEO Brad Schwartz provides an update on how we’re keeping scientists and teams safe during the COVID-19 pandemic.
As of March 18, the Discovery Building, home of the Morgridge Institute for Research, will be closed to the public. All public events in the building are canceled. Visit here for important COVID-19 updates.